{ "cik": 1935979, "cik_padded": "0001935979", "entityName": "Biohaven Ltd.", "fiscal_years": [ { "accn": "0001935979-26-000020", "filed": "2026-03-02", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 715000.0, "cash": 229957000.0, "eps_diluted": -6.86, "free_cash_flow": -610153000.0, "net_income": -738822000.0, "operating_cash_flow": -609438000.0, "operating_income": -745378000.0, "stockholders_equity": 52072000.0, "total_assets": 451447000.0, "total_liabilities": 399375000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 7.669668919956982, "roa_avg2y": -1.3854375868451105, "roa_period_end": -1.6365642035499184, "roe_avg2y": -3.1075060777105747 } }, { "accn": "0001935979-26-000020", "filed": "2026-03-02", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4049000.0, "cash": 99134000.0, "eps_diluted": -9.28, "free_cash_flow": -586502000.0, "net_income": -846422000.0, "operating_cash_flow": -582453000.0, "operating_income": -885111000.0, "stockholders_equity": 423436000.0, "total_assets": 615107000.0, "total_liabilities": 191671000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4526563636535391, "roa_avg2y": -1.5003239332139227, "roa_period_end": -1.3760565234991633, "roe_avg2y": -1.9882806306237528, "roe_period_end": -1.9989372656080258 } }, { "accn": "0001935979-26-000020", "filed": "2026-03-02", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3048000.0, "cash": 248402000.0, "eps_diluted": -5.73, "free_cash_flow": -334773000.0, "net_income": -408168000.0, "operating_cash_flow": -331725000.0, "operating_income": -436051000.0, "stockholders_equity": 427975000.0, "total_assets": 513212000.0, "total_liabilities": 85237000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.19916350254103626, "roa_avg2y": -0.694756998965953, "roa_period_end": -0.7953204523666632, "roe_avg2y": -0.8444162168759943, "roe_period_end": -0.9537192593025293 } }, { "accn": "0001935979-26-000020", "filed": "2026-03-02", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6074000.0, "cash": 204877000.0, "eps_diluted": -12.75, "free_cash_flow": -303763000.0, "net_income": -570279000.0, "operating_cash_flow": -297689000.0, "operating_income": -567932000.0, "stockholders_equity": 538771000.0, "total_assets": 661783000.0, "total_liabilities": 123012000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2283196385848533, "roa_avg2y": -1.4188797826443937, "roa_period_end": -0.8617311112555022, "roe_avg2y": -1.9888990028981868, "roe_period_end": -1.0584812471346825 } }, { "accn": "0001935979-25-000015", "filed": "2025-03-03", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 938000.0, "cash": 76057000.0, "eps_diluted": -5.43, "free_cash_flow": -146778000.0, "net_income": -213796000.0, "operating_cash_flow": -145840000.0, "operating_income": -218900000.0, "stockholders_equity": 34691000.0, "total_assets": 142061000.0, "total_liabilities": 47370000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 1.36548384307169, "roa_period_end": -1.504959137272017, "roe_avg2y": -8.307273857631333 } }, { "accn": "0001935979-24-000010", "filed": "2024-02-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 1097000.0, "cash": 82506000.0, "eps_diluted": -3.01, "free_cash_flow": -77054000.0, "net_income": -118668000.0, "operating_cash_flow": -75957000.0, "operating_income": -114506000.0, "stockholders_equity": 16781000.0 }, "period_end": "2020-12-31", "ratio_units": { "roe_avg2y": "ratio" }, "ratios": { "roe_avg2y": -7.599129098360656 } }, { "accn": "0001935979-23-000009", "filed": "2023-03-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": 14451000.0 }, "period_end": "2019-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001935979-26-000020", "filed": "2026-03-02", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001935979.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001935979.json" }, "ticker": "BHVN" }